Sponsor pipeline

Turning Point Therapeutics, Inc. clinical trial pipeline

Get alerts when Turning Point Therapeutics, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1
1
Phase 1/2
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT04094610 A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR… Locally Advanced Solid Tumors Recruiting 2026-09-25
NCT03093116 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK… Locally Advanced Solid Tumors Recruiting 2026-05-27
Phase 1
NCT03993873 Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors… Advanced Solid Tumor Active, Not Recruiting 2025-10-01

Disease areas by active trials, top 10 of 11

Get alerts when Turning Point Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free